Gestational trophoblastic disease tumours in high risk patients

Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK
Gestational trophoblastic disease tumours in high risk patients ( Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK )
30 Oct 2012

Late effects of treatment in gynaecological cancers

Dr Remi Nout – Leiden University Medical Center, Netherlands
Late effects of treatment in gynaecological cancers ( Dr Remi Nout – Leiden University Medical Center, Netherlands )
30 Oct 2012

Staging in endometrial cancer and sentinel node mapping

Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA
Staging in endometrial cancer and sentinel node mapping ( Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA )
30 Oct 2012

OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer

Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain
OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer ( Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain )
30 Oct 2012

State of PARP inhibitors and anti-angiogenics

Prof Stan Kaye – Royal Marsden Hospital, London, UK
State of PARP inhibitors and anti-angiogenics ( Prof Stan Kaye – Royal Marsden Hospital, London, UK )
29 Oct 2012

Study of ovarian cancer and endometriosis sub-fertility

Prof Curt Burger – Erasmus University, Rotterdam, Netherlands
Study of ovarian cancer and endometriosis sub-fertility ( Prof Curt Burger – Erasmus University, Rotterdam, Netherlands )
29 Oct 2012

New therapies to treat advanced endometrial cancer

Prof Gini Fleming – University of Chicago Medical Center, Illinois, USA
New therapies to treat advanced endometrial cancer ( Prof Gini Fleming – University of Chicago Medical Center, Illinois, USA )
29 Oct 2012

Defining and advancing individualised medicine

Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA
Defining and advancing individualised medicine ( Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA )
29 Oct 2012

Effects of early ovarian cancer screening

Dr Ed Pavlik – University of Kentucky, Lexington, USA
Effects of early ovarian cancer screening ( Dr Ed Pavlik – University of Kentucky, Lexington, USA )
29 Oct 2012

Sexual health during and after ovarian cancer treatment

Dr Susan Carr – Royal Women’s Hospital, Parkville, Australia
Sexual health during and after ovarian cancer treatment  ( Dr Susan Carr – Royal Women’s Hospital, Parkville, Australia )
29 Oct 2012

Treating platinum resistant ovarian cancer

Dr Andres Poveda – Fundacion Instituto Valenciano de Oncologia, Spain
Treating platinum resistant ovarian cancer ( Dr Andres Poveda – Fundacion Instituto Valenciano de Oncologia, Spain )
12 Oct 2012

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012